Olema Pharmaceuticals Inc (OLMA)
Healthcare
Biotechnology
11.50 $
-3.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Olema Pharmaceuticals Inc (OLMA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -147 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -2.2 | -3.1 | -20 | -51 | -82 | -84 | -104 | -147 | |
| 0.0 | 0.0 | 0.0 | 1.7 | 1.7 | 0.4 | 0.4 | 0.5 | |
| 0.0 | 0.0 | 3.1 | 16 | 19 | 17 | 23 | 18 | |
| 0.1 | 3.7 | 3.7 | 17 | 19 | – | – | – | |
| -0.1 | 1.2 | -1.5 | 2.8 | 3.0 | -0.6 | 9.2 | 2.8 | |
| 0.1 | 0.1 | 0.1 | 1.6 | 0.4 | 0.0 | 0.2 | 0.0 | |
| -0.1 | -0.1 | -0.1 | -275 | 91 | -4.9 | -94 | -156 | |
| – | – | 3.1 | – | – | – | – | – | |
| 0.0 | 0.0 | -2.3 | 1.4 | 0.5 | – | – | 1.0 | |
| 0.3 | 3.1 | 3.1 | 0.0 | – | – | 0.0 | 3.0 | |
| 5.3 | 358 | 358 | 1.4 | 0.5 | 133 | 269 | 211 | |
| 3.1 | -3.1 | 338 | -325 | 9.9 | 45 | 71 | -91 | |
| -2.2 | -3.1 | -20 | -52 | -82 | -84 | -105 | -147 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.